Century Health is a New York-based health technology company that turns fragmented, messy electronic health record data into clean, structured, analysis-ready real-world evidence. Its AI-powered platform, CHARM (Century Health Abstraction & Retrieval Model), automates the curation, abstraction, and de-identification of clinical data to build disease-specific patient registries for pharmaceutical and life sciences research. Founded in 2023 by Vish Srivastava and Sanjay Hariharan, the company reports 97% accuracy against clinical expert judgment and raised a $5M seed round in 2026 led by Origin Ventures.
Pascal Metrics is a Washington, DC and Austin-based healthcare data analytics company that turns real-time electronic health record data into clinically validated adverse-event outcomes. As a U.S.-certified Patient Safety Organization (PSO #0047), it operates the Pascal Platform - anchored by trigger-based surveillance and machine-learning models - to help hospitals and health systems detect, predict, and reduce preventable patient harm. Founded in 2007 and named after Blaise Pascal, the 'founder of risk management,' the company claims one of the largest validated adverse-event outcomes datasets in the world.
Drew Ladner is the founding Chairman and CEO of Pascal Metrics, a Washington, D.C. and Austin-based patient safety company that uses real-time EHR data, clinically validated adverse-event outcomes, and machine learning to catch preventable harm in hospitals before it compounds. Since 2007 he has built Pascal into a U.S.-certified Patient Safety Organization serving hundreds of healthcare systems worldwide, with clients identifying roughly 10x more serious harm than legacy methods. Before healthcare, he was CIO of the U.S. Treasury's $2.6 billion IT organization, a general manager at open-source pioneer JBoss, and an operator across Netscape, AOL Time Warner, and microfinance in East Africa. He holds an MBA from Harvard, an MA in theology from Oxford, and a BSFS from Georgetown.
Dan Riskin is a physician-entrepreneur, trauma surgeon, and healthcare AI executive who founded Verantos in 2015 to generate high-validity real-world evidence from messy clinical data. A serial innovator who began coding at age 5 and sold software at 12, Riskin holds an MD from Boston University and an MBA from MIT, is board-certified in four specialties, and serves as Clinical Professor of Surgery at Stanford. His prior company Health Fidelity was acquired for more than $150 million. Today, Verantos powers regulatory and reimbursement decisions for major pharmaceutical companies by turning fragmented EHR data into research-grade evidence at scale.